ACH
insider transactionsACCENDRA HEALTH INC/VA/ — buys & sells by directors, officers and 10% owners A shareholder owning more than 10% of the company. Must report trades, but usually a weaker signal than an officer or director. (SEC Form 4).
No open-market buys or sells this period. The trades below are grants, option exercises and gifts, which carry no market price.
Net buy / sell volume
Not enough data to chart yet.
Tap or hover the chart for daily net volume. Green = net buying, red = net selling.
All transactions
-
Other·F
EVP,General Counsel & CorpSecy
$5.3K
1.8K sh · $2.91
Own -1%
-
Other·F
Jonathan A Leon KEY
EVP & CFO
$5.4K
1.8K sh · $3.04
Own -1%
-
Other·F
Edward A Pesicka KEY
President & CEO
$53.8K
17.7K sh · $3.04
Own -2%
-
Other·F
EVP,General Counsel & CorpSecy
$2.9K
966 sh · $3.04
Own -1%
-
Other·F
EVP, Chief Operating Officer
$24.0K
7.9K sh · $3.04
Own -2%
-
Grant·A
Director
$0
31.2K sh
Own +58%
-
Grant·A
Director
$0
31.2K sh
Own +53%
-
Grant·A
Director
$0
31.2K sh
Own +57%
-
Grant·A
Director
$0
31.2K sh
Own +63%
-
Grant·A
Director
$0
31.2K sh
Own +78%
-
Other·F
Edward A Pesicka KEY
President & CEO
$119.7K
58.9K sh · $2.03
Own -5%
-
Other·F
Jonathan A Leon KEY
EVP & CFO
$22.9K
11.3K sh · $2.03
Own -4%
-
Other·F
EVP, Chief Operating Officer
$42.3K
20.8K sh · $2.03
Own -6%
-
Other·F
EVP,General Counsel & CorpSecy
$19.0K
9.3K sh · $2.03
Own -5%
-
Grant·A
EVP, Chief Operating Officer
$0
108.7K sh
Own +46%
-
Grant·A
Jonathan A Leon KEY
EVP & CFO
$0
85.1K sh
Own +39%
-
Grant·A
EVP,General Counsel & CorpSecy
$0
61.4K sh
Own +53%
| Date▾ | Insider | Type | Shares | Value |
|---|---|---|---|---|
| May 18, 2026 | Heath H Galloway | Other F | 1.8K | $5.3K |
| May 15, 2026 | Jonathan A Leon KEY | Other F | 1.8K | $5.4K |
| May 15, 2026 | Edward A Pesicka KEY | Other F | 17.7K | $53.8K |
| May 15, 2026 | Heath H Galloway | Other F | 966 | $2.9K |
| May 15, 2026 | Perry A Bernocchi | Other F | 7.9K | $24.0K |
| May 14, 2026 | Teresa L. Kline | Grant A | 31.2K | $0 |
| May 14, 2026 | Stephen W Klemash | Grant A | 31.2K | $0 |
| May 14, 2026 | Kenneth Gardner-Smith | Grant A | 31.2K | $0 |
| May 14, 2026 | Gwendolyn M Bingham | Grant A | 31.2K | $0 |
| May 14, 2026 | Mark A Beck | Grant A | 31.2K | $0 |
| Mar 20, 2026 | Edward A Pesicka KEY | Other F | 58.9K | $119.7K |
| Mar 20, 2026 | Jonathan A Leon KEY | Other F | 11.3K | $22.9K |
| Mar 20, 2026 | Perry A Bernocchi | Other F | 20.8K | $42.3K |
| Mar 20, 2026 | Heath H Galloway | Other F | 9.3K | $19.0K |
| Mar 9, 2026 | Perry A Bernocchi | Grant A | 108.7K | $0 |
| Mar 9, 2026 | Jonathan A Leon KEY | Grant A | 85.1K | $0 |
| Mar 9, 2026 | Heath H Galloway | Grant A | 61.4K | $0 |
About ACH insider trading
This page tracks insider transactions for ACCENDRA HEALTH INC/VA/ (ACH) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.